|
業務類別
|
-- |
|
業務概覽
|
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services. |
| 公司地址
| 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL, USA, 33401 |
| 電話號碼
| +1 612 800-0059 |
| 傳真號碼
| -- |
| 公司網頁
| https://foxotechnologies.com |
| 員工數量
| 192 |
| Mr. Seamus Lagan |
Director, Chief Executive Officer and Interim Chief Financial Officer and Principal Accounting Officer |
-- |
13/06/2025 |
| Mr. Mark White |
Director; Chief Executive Officer of FOXO Labs Inc. |
-- |
15/04/2025 |
|
|
| Mr. Seamus Lagan |
Director, Chief Executive Officer and Interim Chief Financial Officer and Principal Accounting Officer |
13/06/2025 |
| Mr. Trevor Langley |
Chairman of the Board |
15/04/2025 |
| Mr. Bret Barnes |
Independent Director |
15/04/2025 |
| Mr. Mark White |
Director; Chief Executive Officer of FOXO Labs Inc. |
15/04/2025 |
| Mr. Francis Colt deWolf, III |
Independent Director |
15/04/2025 |
|
|
|
|